BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16475014)

  • 1. Variable recombination efficiency in responder transgenes activated by Cre recombinase in the vasculature.
    Hara-Kaonga B; Gao YA; Havrda M; Harrington A; Bergquist I; Liaw L
    Transgenic Res; 2006 Feb; 15(1):101-6. PubMed ID: 16475014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission.
    Sakai K; Miyazaki Ji
    Biochem Biophys Res Commun; 1997 Aug; 237(2):318-24. PubMed ID: 9268708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase.
    Araki K; Araki M; Miyazaki J; Vassalli P
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):160-4. PubMed ID: 7816809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cre-mediated recombination efficiency and transgene expression patterns of three retinal bipolar cell-expressing Cre transgenic mouse lines.
    Lu Q; Ivanova E; Ganjawala TH; Pan ZH
    Mol Vis; 2013; 19():1310-20. PubMed ID: 23805038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes.
    Dietrich P; Dragatsis I; Xuan S; Zeitlin S; Efstratiadis A
    Mamm Genome; 2000 Mar; 11(3):196-205. PubMed ID: 10723724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing the doxycycline yields different patterns of genomic recombination in brain neurons with a new inducible Cre transgene.
    Lindeberg J; Mattsson R; Ebendal T
    J Neurosci Res; 2002 Apr; 68(2):248-53. PubMed ID: 11948670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.
    Belteki G; Haigh J; Kabacs N; Haigh K; Sison K; Costantini F; Whitsett J; Quaggin SE; Nagy A
    Nucleic Acids Res; 2005 Mar; 33(5):e51. PubMed ID: 15784609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tetracycline-inducible and skeletal muscle-specific Cre recombinase transgenic mouse.
    Rao P; Monks DA
    Dev Neurobiol; 2009 May; 69(6):401-6. PubMed ID: 19263419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Z/AP, a double reporter for cre-mediated recombination.
    Lobe CG; Koop KE; Kreppner W; Lomeli H; Gertsenstein M; Nagy A
    Dev Biol; 1999 Apr; 208(2):281-92. PubMed ID: 10191045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a tamoxifen-inducible Cre-driver mouse strain for widespread and temporal genetic modification in adult mice.
    Ichise H; Hori A; Shiozawa S; Kondo S; Kanegae Y; Saito I; Ichise T; Yoshida N
    Exp Anim; 2016 Jul; 65(3):231-44. PubMed ID: 26923756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.
    Utomo AR; Nikitin AY; Lee WH
    Nat Biotechnol; 1999 Nov; 17(11):1091-6. PubMed ID: 10545915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly efficient transgene-independent recombination directed by a maternally derived SOX2CRE transgene.
    Vincent SD; Robertson EJ
    Genesis; 2003 Oct; 37(2):54-6. PubMed ID: 14595840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange.
    Wong ET; Kolman JL; Li YC; Mesner LD; Hillen W; Berens C; Wahl GM
    Nucleic Acids Res; 2005 Oct; 33(17):e147. PubMed ID: 16204450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-specific effect associated with conditional transgene expression based on Cre-loxP strategy in mice.
    Qiu L; Rivera-Pérez JA; Xu Z
    PLoS One; 2011 May; 6(5):e18778. PubMed ID: 21572998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgene Coplacement and high efficiency site-specific recombination with the Cre/loxP system in Drosophila.
    Siegal ML; Hartl DL
    Genetics; 1996 Oct; 144(2):715-26. PubMed ID: 8889532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
    Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
    Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.